| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |